Red de Terapias Avanzadas: RICORS TERAV

Advanced Therapies (AT) constitute a new field of modern therapies that has markedly progressed over the past decade, offering new opportunities for the treatment of previously untreatable congenital and acquired diseases. Despite its remarkable evolution, clinical translation of Advanced Therapy Medicinal Products (ATMP) into the clinical practice needs of improvement due to several limitations including their unaffordable costs. The Spanish network on Advanced therapies (TERAV) is borne with the aim of developing innovative approaches of gene and cell therapy that should facilitate: 1) Development of proof-of-concept clinical trials using innovative ATMPs generated in our country, and 2) Protection and transfer of our innovative therapies to the industry, ideally to companies capable of expanding them towards their approval in international Regulatory Agencies, facilitating the treatment of diseases with poor prognosis world-wide.